|
Feb 13
|
Alnylam: Q4 Earnings Snapshot
|
|
Feb 13
|
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Period Progress
|
|
Feb 12
|
Biogen's Q4 Earnings & Sales Beat, 2025 EPS Guidance Disappoints
|
|
Feb 11
|
ILMN vs. ALNY: Which Stock Is the Better Value Option?
|
|
Feb 10
|
Will These 5 Biotech Bigwig Stocks Surpass Q4 Earnings Forecast?
|
|
Feb 10
|
Ahead of Alnylam (ALNY) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
|
|
Oct 2
|
Here's Why You Should Add ALNY Stock to Your Portfolio Right Now
|
|
Oct 1
|
Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?
|
|
Oct 1
|
Not Holding Alnylam Pharmaceuticals (ALNY) Hurt Fidelity Growth Strategies Fund’s Performance
|
|
Sep 29
|
Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024
|
|
Sep 26
|
Alnylam to Webcast TTR Investor Day
|
|
Aug 30
|
Why IBD 50's Alnylam Just Reversed Its 50% Gain — And BridgeBio Surged
|
|
Aug 30
|
Alnylam Stock Falls on Positive but Disappointing Study Results for Heart Drug
|
|
Aug 30
|
ESC 2024: Amvuttra data signals positive prospects in cardiomyopathy for Alnylam
|
|
Aug 30
|
Alnylam Pharmaceuticals Reports Substantial Results of Vutrisiran's Phase 3 Study as Heart Disease Therapy
|
|
Aug 30
|
Alnylam Presents Detailed Results from the Positive HELIOS-B Phase 3 Study of Vutrisiran▼ in Patients with ATTR Amyloidosis with Cardiomyopathy at the European Society of Cardiology Congress
|
|
Aug 30
|
Full study data back Alnylam heart drug’s benefit, but leave doctors with tough choices
|
|
Aug 28
|
Alnylam to Webcast Presentations at Upcoming September Investor Conferences
|
|
Jul 29
|
Analysts Estimate CRISPR Therapeutics AG (CRSP) to Report a Decline in Earnings: What to Look Out for
|
|
Jul 25
|
Alnylam Pharmaceuticals (ALNY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|